Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 8 | 2021 | 218 | 1.260 |
Why?
|
| Proteoglycans | 9 | 2013 | 345 | 0.860 |
Why?
|
| Biglycan | 5 | 2016 | 17 | 0.700 |
Why?
|
| Cartilage, Articular | 11 | 2012 | 550 | 0.620 |
Why?
|
| Intervertebral Disc Degeneration | 4 | 2015 | 130 | 0.570 |
Why?
|
| Lumbar Vertebrae | 3 | 2015 | 523 | 0.550 |
Why?
|
| Chondrocytes | 6 | 2012 | 208 | 0.520 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2009 | 131 | 0.500 |
Why?
|
| Signal Transduction | 5 | 2016 | 498 | 0.450 |
Why?
|
| RNA, Messenger | 7 | 2015 | 329 | 0.420 |
Why?
|
| Extracellular Matrix | 4 | 2010 | 75 | 0.400 |
Why?
|
| Sacrum | 1 | 2011 | 29 | 0.380 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 33 | 0.360 |
Why?
|
| ErbB Receptors | 1 | 2010 | 81 | 0.350 |
Why?
|
| ADAM Proteins | 4 | 2021 | 66 | 0.330 |
Why?
|
| Collagen | 1 | 2009 | 103 | 0.320 |
Why?
|
| Membrane Proteins | 3 | 2021 | 184 | 0.310 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 115 | 0.290 |
Why?
|
| Intervertebral Disc Displacement | 2 | 2011 | 131 | 0.270 |
Why?
|
| Homeostasis | 4 | 2012 | 86 | 0.260 |
Why?
|
| Gene Expression | 4 | 2021 | 239 | 0.220 |
Why?
|
| Osteoarthritis, Knee | 3 | 2009 | 400 | 0.220 |
Why?
|
| Aging | 4 | 2009 | 1727 | 0.220 |
Why?
|
| Low Back Pain | 2 | 2015 | 144 | 0.210 |
Why?
|
| Inflammation | 3 | 2021 | 362 | 0.210 |
Why?
|
| Decorin | 4 | 2009 | 17 | 0.200 |
Why?
|
| Interleukin-1 | 4 | 2013 | 79 | 0.190 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 3 | 2009 | 29 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2021 | 101 | 0.180 |
Why?
|
| Middle Aged | 13 | 2015 | 10239 | 0.180 |
Why?
|
| Cells, Cultured | 6 | 2016 | 686 | 0.170 |
Why?
|
| Adult | 13 | 2015 | 8949 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 5192 | 0.170 |
Why?
|
| Receptors, Calcitriol | 2 | 2016 | 2 | 0.150 |
Why?
|
| Animals | 9 | 2021 | 4724 | 0.150 |
Why?
|
| Young Adult | 3 | 2015 | 2063 | 0.140 |
Why?
|
| Axin Protein | 1 | 2016 | 1 | 0.140 |
Why?
|
| Sensory System Agents | 1 | 2016 | 4 | 0.140 |
Why?
|
| Capsaicin | 1 | 2016 | 11 | 0.140 |
Why?
|
| Substance P | 1 | 2016 | 18 | 0.140 |
Why?
|
| Aged | 10 | 2015 | 10079 | 0.140 |
Why?
|
| Humans | 20 | 2016 | 31070 | 0.140 |
Why?
|
| Fibromodulin | 2 | 2009 | 15 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 133 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2014 | 98 | 0.130 |
Why?
|
| Osteoarthritis, Spine | 1 | 2015 | 7 | 0.130 |
Why?
|
| Zygapophyseal Joint | 1 | 2015 | 46 | 0.120 |
Why?
|
| Joint Capsule | 1 | 2015 | 46 | 0.120 |
Why?
|
| Scoliosis | 1 | 2015 | 36 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2015 | 178 | 0.120 |
Why?
|
| Aggrecans | 3 | 2009 | 157 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 158 | 0.120 |
Why?
|
| Male | 9 | 2015 | 16499 | 0.120 |
Why?
|
| Lectins, C-Type | 3 | 2003 | 111 | 0.120 |
Why?
|
| Fibronectins | 1 | 2014 | 33 | 0.120 |
Why?
|
| Spondylolisthesis | 1 | 2015 | 53 | 0.120 |
Why?
|
| Female | 9 | 2015 | 17018 | 0.120 |
Why?
|
| Ankle Joint | 2 | 2009 | 41 | 0.110 |
Why?
|
| Lactoferrin | 1 | 2013 | 12 | 0.110 |
Why?
|
| Neurons | 1 | 2016 | 378 | 0.110 |
Why?
|
| Polyphenols | 1 | 2012 | 5 | 0.110 |
Why?
|
| Stilbenes | 1 | 2012 | 5 | 0.110 |
Why?
|
| Mice | 5 | 2021 | 1683 | 0.110 |
Why?
|
| Chondrosarcoma | 1 | 2012 | 37 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 287 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 120 | 0.090 |
Why?
|
| Bone Regeneration | 1 | 2011 | 76 | 0.090 |
Why?
|
| Subtalar Joint | 1 | 2010 | 3 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Talus | 1 | 2010 | 12 | 0.090 |
Why?
|
| Adolescent | 5 | 2011 | 2403 | 0.090 |
Why?
|
| Spine | 1 | 2011 | 132 | 0.090 |
Why?
|
| Sex Factors | 1 | 2011 | 510 | 0.090 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lumican | 1 | 2009 | 3 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2009 | 26 | 0.080 |
Why?
|
| Keratan Sulfate | 1 | 2009 | 27 | 0.080 |
Why?
|
| DNA | 1 | 2009 | 124 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 874 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 430 | 0.080 |
Why?
|
| Proteolysis | 2 | 2021 | 13 | 0.080 |
Why?
|
| Collagen Type II | 2 | 2009 | 33 | 0.070 |
Why?
|
| Versicans | 2 | 2002 | 17 | 0.070 |
Why?
|
| Ganglia, Spinal | 2 | 2016 | 68 | 0.060 |
Why?
|
| Cattle | 3 | 2013 | 219 | 0.060 |
Why?
|
| Infant | 5 | 2014 | 578 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2015 | 177 | 0.060 |
Why?
|
| Symporters | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calcitriol | 1 | 2004 | 6 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 5 | 0.060 |
Why?
|
| Sulfates | 1 | 2004 | 16 | 0.060 |
Why?
|
| Rabbits | 2 | 2016 | 286 | 0.060 |
Why?
|
| Vitamin D | 1 | 2004 | 42 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2003 | 54 | 0.060 |
Why?
|
| Cadaver | 2 | 2015 | 380 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 29 | 0.050 |
Why?
|
| Dogs | 1 | 2003 | 264 | 0.050 |
Why?
|
| Skin | 1 | 2003 | 124 | 0.050 |
Why?
|
| Cartilage | 1 | 2003 | 159 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 103 | 0.050 |
Why?
|
| Cytokines | 2 | 2015 | 351 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 80 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2016 | 80 | 0.050 |
Why?
|
| Metalloendopeptidases | 2 | 1998 | 25 | 0.050 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2003 | 281 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 28 | 0.050 |
Why?
|
| Cell Survival | 2 | 2013 | 164 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2016 | 323 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 168 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2002 | 691 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 782 | 0.040 |
Why?
|
| Disease Progression | 1 | 2002 | 830 | 0.040 |
Why?
|
| Osteoarthritis | 3 | 2000 | 384 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2000 | 105 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 124 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2012 | 63 | 0.040 |
Why?
|
| Dactinomycin | 1 | 2016 | 7 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cycloheximide | 1 | 2016 | 10 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Epithelium | 1 | 2016 | 29 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 75 | 0.030 |
Why?
|
| Cytosol | 1 | 2016 | 63 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 81 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 93 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 74 | 0.030 |
Why?
|
| Collagenases | 1 | 1996 | 21 | 0.030 |
Why?
|
| beta Catenin | 1 | 2016 | 50 | 0.030 |
Why?
|
| Receptor, trkA | 1 | 2015 | 9 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 37 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 443 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 48 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 33 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 81 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 127 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 232 | 0.030 |
Why?
|
| Knee Joint | 2 | 2002 | 826 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 468 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2002 | 637 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 873 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 11 | 0.030 |
Why?
|
| Metabolism | 1 | 2012 | 9 | 0.030 |
Why?
|
| Plants | 1 | 2012 | 9 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 14 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 17 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 28 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 61 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 23 | 0.030 |
Why?
|
| Proteins | 1 | 2012 | 73 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 65 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 34 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 272 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 172 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 260 | 0.020 |
Why?
|
| Child | 3 | 2002 | 1431 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 275 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 52 | 0.020 |
Why?
|
| Xanthones | 1 | 2009 | 2 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 7 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 66 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2009 | 22 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 47 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2009 | 204 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2009 | 127 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 27 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 28 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 32 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 53 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 27 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 38 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 126 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 2003 | 3 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 181 | 0.010 |
Why?
|
| Liver | 1 | 2004 | 184 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 24 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 59 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2001 | 7 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 46 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 45 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 124 | 0.010 |
Why?
|
| Phenazines | 1 | 1998 | 5 | 0.010 |
Why?
|
| ADAM10 Protein | 1 | 1998 | 5 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 1998 | 17 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1998 | 13 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 107 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 28 | 0.010 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 1996 | 7 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1996 | 24 | 0.010 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1996 | 11 | 0.010 |
Why?
|
| Logistic Models | 1 | 1997 | 410 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 134 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 195 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 247 | 0.010 |
Why?
|